These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 15175797

  • 1. Plasma homocysteine concentration is not associated with activated protein C resistance in patients investigated for hypercoagulability.
    Zarychanski R, Houston DS.
    Thromb Haemost; 2004 Jun; 91(6):1115-22. PubMed ID: 15175797
    [Abstract] [Full Text] [Related]

  • 2. Intraindividual consistency of the activated protein C resistance phenotype.
    Tosetto A, Simioni M, Madeo D, Rodeghiero F.
    Br J Haematol; 2004 Aug; 126(3):405-9. PubMed ID: 15257714
    [Abstract] [Full Text] [Related]

  • 3. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
    Ivey LM, Thom JY, Ivey JG, Baker RI.
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
    [Abstract] [Full Text] [Related]

  • 4. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM, Simioni P, Bernardi F, Tormene D, Lunghi B, Tans G, Pagnan A, Rosing J, Castoldi E.
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors.
    Taralunga C, Gueguen R, Visvikis S, Regnault V, Sass C, Siest G, Lecompte T, Wahl D.
    Br J Haematol; 2004 Aug; 126(3):392-7. PubMed ID: 15257712
    [Abstract] [Full Text] [Related]

  • 6. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of phenotype resistance to activated protein C (APC resistance)].
    Hudecek J, Ivanková J, Dobrotová M, Hybenová J, Pullmann R, Kubisz P.
    Vnitr Lek; 1999 Dec; 45(12):723-8. PubMed ID: 10951849
    [Abstract] [Full Text] [Related]

  • 8. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B.
    Semin Thromb Hemost; 1999 Dec; 25(3):273-89. PubMed ID: 10443959
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL, Welsh CH, Qamar Z, Marlar RA.
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF, Lensen RP, Bertina RM.
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [Abstract] [Full Text] [Related]

  • 15. Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistance.
    Govers-Riemslag JW, Castoldi E, Nicolaes GA, Tans G, Rosing J.
    Thromb Haemost; 2002 Sep; 88(3):444-9. PubMed ID: 12353074
    [Abstract] [Full Text] [Related]

  • 16. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [Abstract] [Full Text] [Related]

  • 17. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, Girolami A.
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.